B4GALT4 and prostate adenocarcinoma: Notably, the CERES scores of B4GALT4 and SULT1E1 were not less than zero in some prostate cancer cell lines, indicating that B4GALT4 and SULT1E1 might not play an inhibitory role in PRAD.